X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
adult (8) 8
aged (7) 7
female (7) 7
hematology (7) 7
male (7) 7
middle aged (7) 7
cxcr4 antagonist (6) 6
immunology (6) 6
receptors, cxcr4 - antagonists & inhibitors (6) 6
heterocyclic compounds - administration & dosage (5) 5
heterocyclic compounds - adverse effects (5) 5
index medicus (5) 5
transplantation (5) 5
adolescent (4) 4
care and treatment (4) 4
chemokine receptor (4) 4
colony-stimulating factor (4) 4
granulocyte colony-stimulating factor - administration & dosage (4) 4
hematology, oncology and palliative medicine (4) 4
hematopoietic stem cell mobilization - methods (4) 4
plerixafor (4) 4
amd3100 (3) 3
anti-hiv agents - administration & dosage (3) 3
bacterial proteins - genetics (3) 3
g-csf (3) 3
hematopoietic progenitor cells (3) 3
hematopoietic stem cell mobilization (3) 3
heterocyclic compounds - pharmacokinetics (3) 3
high-dose chemotherapy (3) 3
multiple myeloma (3) 3
multiple-myeloma (3) 3
pseudomonas - genetics (3) 3
rapid mobilization (3) 3
treatment outcome (3) 3
antagonist (2) 2
anti-hiv agents - adverse effects (2) 2
anti-hiv agents - pharmacokinetics (2) 2
anti-hiv agents - therapeutic use (2) 2
antigens, cd34 (2) 2
antigens, cd34 - blood (2) 2
autologous transplantation (2) 2
bacterial proteins - metabolism (2) 2
blood component removal (2) 2
blood stem-cells (2) 2
bone-marrow (2) 2
bone-marrow-transplantation (2) 2
breast-cancer (2) 2
cohort studies (2) 2
colony-stimulating factors (2) 2
drug synergism (2) 2
engraftment kinetics (2) 2
genetic aspects (2) 2
genetic loci (2) 2
granulocyte colony-stimulating factor - adverse effects (2) 2
granulocyte colony-stimulating factor - pharmacology (2) 2
hematopoietic stem cells (2) 2
hematopoietic stem cells - cytology (2) 2
hematopoietic stem cells - drug effects (2) 2
heterocyclic compounds - pharmacology (2) 2
heterocyclic compounds - therapeutic use (2) 2
hiv infections - drug therapy (2) 2
hiv-1 - drug effects (2) 2
hiv-1 - physiology (2) 2
hoppsya protein (2) 2
hrc gene (2) 2
hrp gene (2) 2
human-immunodeficiency-virus (2) 2
immunodeficiency-virus type-1 (2) 2
infectious diseases (2) 2
lymphoma, non-hodgkin - therapy (2) 2
mosaicism (2) 2
multidisciplinary sciences (2) 2
multiple myeloma - therapy (2) 2
non-hodgkin's lymphomas (2) 2
operator regions (2) 2
paper (2) 2
pharmacokinetics (2) 2
plus g-csf (2) 2
progenitor cells (2) 2
pseudomonas - metabolism (2) 2
randomized-trial (2) 2
research (2) 2
secretion (2) 2
stem cell mobilization (2) 2
stem cell transplantation (2) 2
stem-cells (2) 2
transplantation, autologous (2) 2
adhesion molecules (1) 1
aminoquinolines - administration & dosage (1) 1
aminoquinolines - adverse effects (1) 1
aminoquinolines - therapeutic use (1) 1
analysis (1) 1
anti-retroviral hiv (1) 1
antibiotics (1) 1
antigens, cd - blood (1) 1
antigens, cd34 - analysis (1) 1
antigens, cd34 - drug effects (1) 1
antigens, cd34 - metabolism (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 3/2009, Volume 48, Issue 6, pp. 798 - 805
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2008, Volume 14, Issue 11, pp. 1253 - 1261
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2009, Volume 15, Issue 2, pp. 249 - 256
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 10/2004, Volume 37, Issue 2, pp. 1253 - 1262
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2007, Volume 110, Issue 11, pp. 2878 - 2878
Abstract Introduction: Plerixafor (AMD3100) is a first-in-class, small molecule inhibitor of the CXCR4 chemokine receptor that blocks binding of its cognate... 
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 3383 - 3383
Abstract Background: AMD3100 potentiates the effect of G-CSF (Filgrastim) to mobilize hematopoietic PBPCs from the bone marrow into peripheral blood (PB) and... 
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 3381 - 3381
Abstract Background: The addition of AMD3100 to a G-CSF mobilization regimen increases the number of hematopoietic stem and progenitor cells (HSPCs) that can... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 03/2009, Volume 48, Issue 6, p. 798
  The X4 Antagonist Concept Trial investigates the safety and antiviral activity of AMD11070, a potent inhibitor of X4...tropic human immunodeficiency virus... 
Human immunodeficiency virus--HIV | Bioavailability | Clinical medicine | Ribonucleic acid--RNA | Drug dosages | Patients
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 5218 - 5218
Abstract Background: AMD3100, an inhibitor of SDF1 binding to CXCR4, synergizes with G-CSF to allow mobilization of sufficient CD34+ cells/kg for autologous... 
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 5219 - 5219
Abstract Background: High dose chemotherapy with autologous stem cell transplantation (ASCT) improves disease free and overall survival in pts with MM; tandem... 
Journal Article
Blood, ISSN 0006-4971, 11/2005, Volume 106, Issue 11, pp. 154 - 154
Abstract AMD3100 (A), an inhibitor of SDF-1∞ binding to CXCR4, has been used alone and with G-CSF (G) to mobilize CD34+ cells from healthy volunteers and... 
Journal Article